A gripping plea for public debate, this program offers a dynamic cross-section of views on xenotransplantation and the ethical questions it is raising. Bioethicists, researchers, academics, medical professionals, and others from institutions and companies such as Harvard Medical School, the University of Oxford, the Centers for Disease Control and Prevention, PPL Therapeutics, and Immerge BioTherapeutics shed light on a number of pivotal issues. Among...